---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-119533"
form_type: "8-K"
ticker: "ESPR"
cik: "0001434868"
company_name: "Esperion Therapeutics, Inc."
filed_at: "2022-11-16T23:59:59+00:00"
generated_at: "2026-06-21T17:24:06.377630+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Esperion appoints Ben Halladay as CFO, effective Nov 16, 2022

## Summary
- Ben Halladay appointed CFO effective Nov 16, 2022; previously Senior Director of FP&A at Esperion.
- Annual base salary of $429,000; target annual bonus of 40% of base salary.
- Reports to CEO Sheldon Koenig; prior roles at National Oilwell Varco, BMC Software, and Pfizer.
- Holds CPA license; BA from Syracuse University and MBA from Fordham Gabelli School of Business.

## SEC filing metadata
- accession: 0001104659-22-119533
- form_type: 8-K
- ticker: ESPR
- cik: 0001434868
- company_name: Esperion Therapeutics, Inc.
- filed_at: 2022-11-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434868/000110465922119533/0001104659-22-119533-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434868/000110465922119533/tm2230242d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-119533
- JSON: https://secwatch.observer/filing/0001104659-22-119533.json
- Plain text: https://secwatch.observer/filing/0001104659-22-119533.txt

## Key facts
- Executive change
  Benjamin Halladay was appointed as Chief Financial Officer at Esperion Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On November 16, 2022, the board of directors (the “Board”) of Esperion Therapeutics, Inc. (the “Company”) appointed Benjamin Halladay as the Company’s Chief Financial Officer pursuant to the terms of an employment agreement with Mr. Halladay (the “Halladay Agreement”), effective as of November 16, 2022 (the “Commencement Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1434868/000110465922119533/0001104659-22-119533-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.